Combined effects of transcraniel Direct Current Stimulation and cognitive remediation on impairments in executive functions in patients with schizophrenia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022351

Enrollment

Registered

2020-07-09

Start date

2020-05-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F20 F25.1

Interventions

Group 1: cognitive remediation therapy + transcranial Direct Current Stimulation with 2 mA for 20 Minutes, Anode F3, Cathode Fp2, according to international 10-20 EEG-System, 4 times a week for 3 week

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Diagnosis F2.

Exclusion criteria

Exclusion criteria: Neurological Disorder Substance Abuse lacking capacity to consent

Design outcomes

Primary

Measure	Time frame
Performance in a standardized neuropsychological test-battery, focussing on executive functions. The testbattery comprises: - the testset COGBAT as well as the test SWITCH from the Vienna Testing System - CVLT - verbal fluence (German Version: RWT) - Digit span and Digit span backwards and sequentiell as well as digit-letter-span from the WAIS-IV German Version. The neuropsychological testing will be carried out before and after the Intervention Phase of three weeks.	—

Measure

Time frame

Performance in a standardized neuropsychological test-battery, focussing on executive functions. The testbattery comprises: - the testset COGBAT as well as the test SWITCH from the Vienna Testing System - CVLT - verbal fluence (German Version: RWT) - Digit span and Digit span backwards and sequentiell as well as digit-letter-span from the WAIS-IV German Version. The neuropsychological testing will be carried out before and after the Intervention Phase of three weeks.

—

Secondary

Measure	Time frame
Change in clinical outcome assessed using standardized rating scales: MADRS PANSS BDI-II	—

Countries

Germany

Contacts

Public ContactSteffen Aschenbrenner

SRH-Klinikum Karlsbad-Langensteinbach

steffen.aschenbrenner@srh.de07202-61-3496

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026